Mei has been living with breast cancer since 1996 and has tried nearly a dozen different cancer medications—each with difficult side effects. That changed when she began taking a new drug called elacestrant, approved by the FDA in 2023 after clinical trials at Duke howed its effectiveness. For the first time in decades, Mei is experiencing real progress—without the side effects. Elacestrant was discovered in the lab of Dr. Donald McDonnell, a cancer pharmacology professor at Duke University. Its path from lab bench to lifesaving treatment is a powerful example of what’s possible through long-term federal investment in biomedical research—and the vital role universities play in turning discoveries into real-world impact. Hear Mei’s story. Discover the science. And see how Duke research saves lives. #breastcancer #breastcancerawareness #research Find out more about Dr. McDonnell's path to discovering Elacestrant could help breast cancer patients: today.duke.edu/2025/04/how-d...